BOSTON SCIENTIFIC CORPORATION for BOSTON SCIENTIFIC CORPORATION
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
S. 232 - Medical Device Access and Innovation Protection Act - repeals the 2.3% excise tax medical devices H.R. 523 - Protect Medical Innovation Act - repeals the 2.3% excise tax medical devicesH.R. 905 - Research and Development Tax Credit Extension Act of 2013 - Amends the Internal Revenue Code to: (1) make permanent the tax credit for increasing research activities, (2) increase the rate of the alternative simplified research tax credit H.R. 1295 - Medical Device Tax Elimination Act - Extends and enhances R&P tax credit H.R. 905 - Research and Development Tax Credit Extension Act of 2013 Comprehensive/Corporate tax reform Chairman's W&M Discussion Draft - Including lower corporate tax rate, research credit transition and base erosion.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDA BECKER | — |
| KRISTEN HEDSTROM | — |
| STEVEN NEIL LAPIERRE | — |
Copyright/Patent/Trademark CPT
H.R. 2024 - End Anonymous Patents Act -- A bill to end frivolous Patent lawsuits H.R. 845 - Saving High-Tech Innovations from Egregious Legal Disputes Act of 2013 - A bill to end frivolous Patent lawsuits S. 1013 - Patent Abuse Reduction Act of 2013 - A bill to end frivolous Patent lawsuits S. 866 - Patent Quality Improvement Act of 2013 - A bill to end frivolous Patent lawsuitsYet to be introduced - Chairman Goodlatte discussion draft - To end frivolous Patent lawsuits S.1013 -- Patent Abuse Reduction Act of 2013 (Cornyn) S.866 -- Patent Quality Improvement Act of 2013 (Schumer) H.R.2766 -- STOP Act - To make improvements to the transitional program for covered business method patents, and for other purposes (Issa/Chu)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTEN HEDSTROM | — |
| STEVEN NEIL LAPIERRE | — |
| CHRISTOPHER LEE TIMMERMAN | — |
Health Issues HCR
Implementation Food and Drug Administration Safety and Innovation Act FDASIA - Public Law 112-144 H.R. 1919 - Safeguarding Pharmaceuticals Act of 2013 - Track and Trace Pedigree Program S. 957 - Drug Supply Chain Security Act - Track and Trace Pedigree Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDA BECKER | — |
| KRISTEN HEDSTROM | — |
| STEVEN NEIL LAPIERRE | — |
| CHRISTOPHER LEE TIMMERMAN | — |
Budget/Appropriations BUD
H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013 -- Specifically provisions providing appropriations for the FDA's Center for Device and Radiological Health (CDRH) evaluation of medical technology -- In particular have been working on relief of 5% sequestration of user fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTEN HEDSTROM | — |
| STEVEN NEIL LAPIERRE | — |
| CHRISTOPHER LEE TIMMERMAN | — |
Computer Industry CPI
H.R. 624 - CyberIntelligence Sharing & Protection Act (CISPA) of 2013 - A bill to promote Industry and Government sharing of cyber intelligence
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENDA BECKER | — |
| KRISTEN HEDSTROM | — |
| STEVEN NEIL LAPIERRE | — |
Education EDU
S. 358 - STEM Master Teacher Corps Act of 2013 H.R. 1243 - Innovation Inspiration School Grant Program Act - to promote STEM education H.R. 1089 - Stepping up to STEM Act of 2013 - to promote STEM education
| Lobbyist | Covered position, as disclosed |
|---|---|
| KRISTEN HEDSTROM | — |
| STEVEN NEIL LAPIERRE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.